Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

NFL-10808 silences presynaptic serotonin 5-HT1A receptors and has antidepressant effects in vivo

Sep. 21, 2010

Scientists reveal predictors of adverse events associated with losartan therapy for heart failure

Sep. 21, 2010

Almirall identifies new naphthyridine N-oxide as anti-inflammatory agent

Sep. 21, 2010

Ramucirumab is tolerated in patients with advanced HCC in ongoing phase II trial

Sep. 21, 2010

VX-770 shows promise in patients with cystic fibrosis

Sep. 20, 2010

Polymorphic variants in HTR2A gene may predict extent of musculoskeletal pain

Sep. 20, 2010

Aviptadil does not improve pulmonary vascular resistance in phase II trial in PAH

Sep. 20, 2010

Researchers describe new mPTP inhibitors

Sep. 20, 2010

Domain Therapeutics describes new adenosine A2A and A3 receptor antagonists

Sep. 17, 2010

DHEAS levels in plasma identified as putative biomarker for fibromyalgia

Sep. 17, 2010

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...